Basic Information
| RNALocate ID: | RLID:11000716 |
| RNA Symbol: | hsa-miR-19a-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-19a-3p |
| RNA ID: | miRBase:MIMAT0000073 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 25184951 |
| Tissue/Cell Line: | Human esophageal cancer cell line (EC9706) |
| Method: | Next-generation RNA sequencing |
| Description: | All known miRNAs in exosomes were detected at lower levels compared with their corresponding cells, whereas several novel miRNAs in exosomes were detected at higher levels compared with their corresponding cells. Data are collected from Table 3. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001278 | Cytoplasm | Colon cancer cells | 20864815 |
| RLID:01001279 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001280 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001281 | Nucleolus | Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001282 | Nucleus | Neural progenitor cells | 21363885 |
| RLID:11000710 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000711 | Exosome | Renal cancer cells | 21670082 |
| RLID:11000712 | Exosome | Breast milk | 22211110 |
| RLID:11000713 | Exosome | Brain tissue | 23382797 |
| RLID:11000714 | Exosome | Plasma | 23663360 |
| RLID:11000715 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11000717 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
| RLID:11000718 | Exosome | Cerebrospinal fluid | 25420022 |
| RLID:11000719 | Extracellular Vesicle | Liposarcoma cell lines (Lipo246|Lipo863|LPS141)|Preadipocytes | 28588009 |
| RLID:11000720 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11000721 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11000722 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11000723 | Microvesicle | Cerebrospinal fluid | 24797360 |
| RLID-D:11000010 | Exosome | B lymphoblastoid cells|Colon tissue|Endothelial cells|Lymphoma tissue | |
| RLID-D:11000272 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-19a-3p | Splenic marginal zone lymphoma | MNDR-E-MI-25274 |
| MNDR | hsa-miR-19a-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-25275 |
| MNDR | hsa-miR-19a-3p | Oral squamous cell carcinoma | MNDR-E-MI-25276 |
| MNDR | hsa-miR-19a-3p | Large cell neuroendocrine cancer | MNDR-E-MI-25277 |
| MNDR | hsa-miR-19a-3p | Follicular cleaved lymphoma | MNDR-E-MI-25278 |
| MNDR | hsa-miR-19a-3p | Medulloblastoma | MNDR-E-MI-25279 |
| MNDR | hsa-miR-19a-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-25280 |
| MNDR | hsa-miR-19a-3p | Spinocerebellar ataxia type 1 | MNDR-E-MI-25281 |
| MNDR | hsa-miR-19a-3p | Autism spectrum disorder | MNDR-E-MI-25282 |
| MNDR | hsa-miR-19a-3p | Lymphoma | MNDR-E-MI-25283 |
| MNDR | hsa-miR-19a-3p | Lymphoma non-hodgkin | MNDR-E-MI-25284 |
| MNDR | hsa-miR-19a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-25285 |
| MNDR | hsa-miR-19a-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-25286 |
| MNDR | hsa-miR-19a-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-25287 |
| MNDR | hsa-miR-19a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-25288 |
| MNDR | hsa-miR-19a-3p | Her2-receptor positive breast cancer | MNDR-E-MI-25289 |
| MNDR | hsa-miR-19a-3p | Breast cancer luminal | MNDR-E-MI-25290 |
| MNDR | hsa-miR-19a-3p | Niemann-pick disease type c | MNDR-E-MI-25291 |
| MNDR | hsa-miR-19a-3p | Lymphoblastic lymphoma | MNDR-E-MI-25292 |
| MNDR | hsa-miR-19a-3p | Thyroid carcinoma anaplastic | MNDR-E-MI-25293 |
| MNDR | hsa-miR-19a-3p | Prostate cancer | MNDR-E-MI-25294 |
| MNDR | hsa-miR-19a-3p | Gastric cancer | MNDR-E-MI-25295 |
| MNDR | hsa-miR-19a-3p | Gastric lymphoma | MNDR-E-MI-25296 |
| MNDR | hsa-miR-19a-3p | Alzheimer disease | MNDR-E-MI-25297 |
| MNDR | hsa-miR-19a-3p | Intracranial aneurysm | MNDR-E-MI-25298 |
| MNDR | hsa-miR-19a-3p | Bladder cancer | MNDR-E-MI-25299 |
| MNDR | hsa-miR-19a-3p | Esophageal carcinoma | MNDR-E-MI-25300 |
| MNDR | hsa-miR-19a-3p | Dysautonomia familial | MNDR-E-MI-25301 |
| MNDR | hsa-miR-19a-3p | Head and neck cancer | MNDR-E-MI-25302 |
| MNDR | hsa-miR-19a-3p | Leukemia | MNDR-E-MI-25303 |
| MNDR | hsa-miR-19a-3p | Huntington disease | MNDR-E-MI-25304 |
| MNDR | hsa-miR-19a-3p | Cardiovascular disease | MNDR-E-MI-25305 |
| MNDR | hsa-miR-19a-3p | Moyamoya disease | MNDR-E-MI-25306 |
| MNDR | hsa-miR-19a-3p | Lung cancer | MNDR-E-MI-25307 |
| MNDR | hsa-miR-19a-3p | Parkinson disease | MNDR-E-MI-25308 |
| MNDR | hsa-miR-19a-3p | Machado-joseph disease | MNDR-E-MI-25309 |
| MNDR | hsa-miR-19a-3p | Niemann-pick disease | MNDR-E-MI-25310 |
| MNDR | hsa-miR-19a-3p | Basal-like breast cancer | MNDR-E-MI-25311 |
| MNDR | hsa-miR-19a-3p | Congenital heart disease | MNDR-E-MI-25312 |
| MNDR | hsa-miR-19a-3p | Neuroendocrine neoplasia | MNDR-E-MI-25313 |
| MNDR | hsa-miR-19a-3p | Pancreatic cancer | MNDR-E-MI-25314 |
| MNDR | hsa-miR-19a-3p | Melanoma | MNDR-E-MI-25315 |
| MNDR | hsa-miR-19a-3p | Rectum adenocarcinoma | MNDR-E-MI-25316 |
| MNDR | hsa-miR-19a-3p | Nephroblastoma | MNDR-E-MI-25317 |
| MNDR | hsa-miR-19a-3p | Colon cancer | MNDR-E-MI-25318 |
| MNDR | hsa-miR-19a-3p | Colon adenocarcinoma | MNDR-E-MI-25319 |
| MNDR | hsa-miR-19a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-25320 |
| MNDR | hsa-miR-19a-3p | Familial ovarian cancer | MNDR-E-MI-25321 |
| MNDR | hsa-miR-19a-3p | Prostate adenocarcinoma | MNDR-E-MI-25322 |
| MNDR | hsa-miR-19a-3p | Thyroid adenomas | MNDR-E-MI-25323 |
| MNDR | hsa-miR-19a-3p | Carcinoma ductal breast | MNDR-E-MI-25324 |
| MNDR | hsa-miR-19a-3p | Glioblastoma | MNDR-E-MI-25325 |
| MNDR | hsa-miR-19a-3p | Astrocytoma | MNDR-E-MI-25326 |
| MNDR | hsa-miR-19a-3p | Glioma | MNDR-E-MI-25327 |
| MNDR | hsa-miR-19a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-25328 |
| MNDR | hsa-miR-19a-3p | Osteosarcoma | MNDR-E-MI-25329 |
| MNDR | hsa-miR-19a-3p | Liposarcoma | MNDR-E-MI-25330 |
| MNDR | hsa-miR-19a-3p | Cervical adenocarcinoma | MNDR-E-MI-25331 |
| MNDR | hsa-miR-19a-3p | Gastric adenocarcinoma | MNDR-E-MI-25332 |
| MNDR | hsa-miR-19a-3p | Cervical squamous cell carcinoma | MNDR-E-MI-25333 |
| MNDR | hsa-miR-19a-3p | Lung squamous cell carcinoma | MNDR-E-MI-25334 |
| MNDR | hsa-miR-19a-3p | Lung adenocarcinoma | MNDR-E-MI-25335 |
| MNDR | hsa-miR-19a-3p | Adrenocortical cancer | MNDR-E-MI-25336 |
| MNDR | hsa-miR-19a-3p | Thyroid carcinoma | MNDR-E-MI-25337 |
| MNDR | hsa-miR-19a-3p | Bladder urothelial carcinoma | MNDR-E-MI-25338 |
| MNDR | hsa-miR-19a-3p | Carcinoma renal cell | MNDR-E-MI-25339 |
| MNDR | hsa-miR-19a-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-25340 |
| MNDR | hsa-miR-19a-3p | Renal clear cell carcinoma | MNDR-E-MI-25341 |
| MNDR | hsa-miR-19a-3p | Cholangiocarcinoma | MNDR-E-MI-25342 |
| MNDR | hsa-miR-19a-3p | Esophageal cancer | MNDR-E-MI-25343 |
| MNDR | hsa-miR-19a-3p | Lung small cell carcinoma | MNDR-E-MI-25344 |
| MNDR | hsa-miR-19a-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-25345 |
| MNDR | hsa-miR-19a-3p | Notch-induced t-cell acute lymphoblastic leukemia | MNDR-E-MI-25346 |
| MNDR | hsa-miR-19a-3p | Cowden disease | MNDR-E-MI-25347 |
| MNDR | hsa-miR-19a-3p | Breast invasive carcinoma | MNDR-E-MI-25348 |
| MNDR | hsa-miR-19a-3p | Hepatocellular carcinoma | MNDR-E-MI-25349 |
| MNDR | hsa-miR-19a-3p | Familiar ovarian carcinoma | MNDR-E-MI-25350 |
| MNDR | hsa-miR-19a-3p | B-cell lymphoma | MNDR-E-MI-25351 |
| MNDR | hsa-miR-19a-3p | Rheumatoid arthritis | MNDR-E-MI-25352 |
| MNDR | hsa-miR-19a-3p | T-cell leukemia | MNDR-E-MI-25353 |
| MNDR | hsa-miR-19a-3p | Malignant pleural mesothelioma | MNDR-E-MI-25354 |
| MNDR | hsa-miR-19a-3p | Cervical carcinoma | MNDR-E-MI-25355 |
| MNDR | hsa-miR-19a-3p | Retinoblastoma | MNDR-E-MI-25356 |
| MNDR | hsa-miR-19a-3p | Neuroblastoma | MNDR-E-MI-25357 |
| MNDR | hsa-miR-19a-3p | Barrett's adenocarcinoma | MNDR-E-MI-25358 |
| MNDR | hsa-miR-19a-3p | Hodgkin lymphoma | MNDR-E-MI-25359 |
| MNDR | hsa-miR-19a-3p | Ulcerative colitis | MNDR-E-MI-25360 |
| MNDR | hsa-miR-19a-3p | Burkitt lymphoma | MNDR-E-MI-25361 |
| MNDR | hsa-miR-19a-3p | Lymphosarcoma | MNDR-E-MI-25362 |
| MNDR | hsa-miR-19a-3p | Crohn disease | MNDR-E-MI-25363 |
| MNDR | hsa-miR-19a-3p | Tonsil cancer | MNDR-E-MI-25364 |
| MNDR | hsa-miR-19a-3p | Psoriasis | MNDR-E-MI-25365 |
| MNDR | hsa-miR-19a-3p | Acute myelogenous leukemia | MNDR-E-MI-25366 |
| MNDR | hsa-miR-19a-3p | Colorectal cancer | MNDR-E-MI-25367 |
| MNDR | hsa-miR-19a-3p | Nasopharynx carcinoma | MNDR-E-MI-25368 |
| MNDR | hsa-miR-19a-3p | Acute myocardial infarction | MNDR-E-MI-25369 |
| MNDR | hsa-miR-19a-3p | Multiple myeloma | MNDR-E-MI-25370 |
| MNDR | hsa-miR-19a-3p | Esophageal squamous cell carcinoma | MNDR-E-MI-25371 |
| MNDR | hsa-miR-19a-3p | Ependymoma | MNDR-E-MI-25372 |
| MNDR | hsa-miR-19a-3p | Nasopharyngeal cancer | MNDR-E-MI-25373 |
| MNDR | hsa-miR-19a-3p | Prostatic neoplasms | MNDR-E-MI-25374 |
| MNDR | hsa-miR-19a-3p | Pseudorabies | MNDR-E-MI-25375 |
| MNDR | hsa-miR-19a-3p | Aids dementia complex | MNDR-E-MI-25376 |
| MNDR | hsa-miR-19a-3p | Epstein-barr virus infections | MNDR-E-MI-25377 |
| MNDR | hsa-miR-19a-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-25378 |
| MNDR | hsa-miR-19a-3p | Arsenic poisoning | MNDR-E-MI-25379 |
| MNDR | hsa-miR-19a-3p | Chronic pain | MNDR-E-MI-25380 |
| MNDR | hsa-miR-19a-3p | Stroke lacunar | MNDR-E-MI-25381 |
| MNDR | hsa-miR-19a-3p | Barrett's carcinogenesis | MNDR-E-MI-25382 |
| MNDR | hsa-miR-19a-3p | Breast cancer her3+ negative | MNDR-E-MI-25383 |
| MNDR | hsa-miR-19a-3p | Duke A | MNDR-E-MI-25384 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCA1 | Homo sapiens | RR00022102 |
TOP